Health status measures in rheumatoid arthritis that have been extensively validated for use in clinical trials are generally used also in correlative studies, e.g. to predict future health status. This application requires stability (repeatability of measurements). The purpose of our study was to determine the stability of commonly used health status measures. Two measurements at an interval of 6 months were taken in 99 patients. High stability (a = 0.78 to 0.94) was observed for five biomedical measures (grip strength, walking time, platelet count, haemoglobin and erythrocyte sedimentation rate) and five self-report measures (mobility, self care, impact daily activities, anxiety and cheerful mood). Moderate stability (a = 0.65 to 0.72) was observed for joint scores, pain, C-reactive protein and depressive mood. The highly stable measures most adequately reflect individual differences, may be applied most reliably in correlative studies and appear to have the largest clinical utility with regard to long-term prediction of health status. K ey w o r d s : Rheumatoid arthritis, Stability, Reliability, Validity, Outcome measures, Clinimetrics.
In rheumatoid arthritis (RA) health status measure ment for the purpose of therapy evaluation has been the subject of extensive research and has been validated in several ways [1, 2] . Recently, recommendations on the use of process and outcome measures [3] , defini tions of clinically im portant changes in patients and groups [4] and a core set of disease activity measures in clinical trials of RA patients have been published [5] .
The same measures that have been validated for the purpose of evaluation are generally used also in correl ative studies, examining whether health status variables predict future health status or vary concomitantly with other variables (e.g. demographic, biological or social variables). However, in correlative studies other con siderations should guide the choice of variables than those used in evaluation studies. In evaluation studies the ability of a measure to detect intra-individual change in response to treatment is important. Variance due to change, the responsiveness coefficient, reflects this property [6] . In correlative studies the ability of a measure to discriminate between individuals is important. Discrimination refers to variation between individuals. This property is reflected in the stability coefficient and other reliability coefficients [6] , Stability s to the extent to which measurements are the same when retested after some period of time. Stability is determined by: (a) repeatability (or changeability) of measurements and (b) the range of inter-individual differences. When variation between individuals is small then even minor intra-individual changes in health status may reduce stability. But when individual differences are large then even clinically relevant intra individual changes may only marginally affect the relative position of patients towards each other, and stability will be high.
Stability has hardly been investigated systematically [7] or only for very short intervals between measure ments [8] [9] [10] . A single measurement of health status reflects first of all enduring differences between indi viduals, i.e. the irreversible outcome of the disease and other stable aspects of individuals such as consti tutional differences. But a single assessment also reflects current disease activity and other temporary fluctuations such as seasonal variations and inaccuracy of measurements [7] . Whatever the cause of low stability, fluctuations of the disease or measurement error, if a health status measure predominantly reflects a transient state, little can be expected when measure is correlated with enduring aspects of persons or when it is used to predict future health status. The first and most important purpose of stability analysis is to quantify the extent to which health status measures in RA reflect stable individual differences.
In correlative studies conclusions are often based on single measurements, based on the assumption that these assessments reflect to a large extent stable individual differences between patients. Except for pain assessment [11] , validation of this current practice to infer from periodic single assessments has not gained much attention. The second purpose of analysis is to determine whether it is meaningful to infer from a single assessment, e.g. to predict future health status.
If a single assessment of a variable proves to be unsuitable for prediction purposes, one could use: (a) composite measures of multiple variables or (b) the mean of repeated measurements of the same variable » ««ni, s >hn [11] [12] [13] . The mean of repeated measurements of a variable more accurately reflects relatively enduring characteristics of patients than does a single measure ment. This mean is consequently more appropriate to predict future health status. Stability analysis provides the tools to estimate the number of measurements needed to arrive at a mean value that adequately reflects individual differences. This is the third purpose of stability analysis.
The aim of the present study was to quantify the stability of commonly used measures of health status in RA in order to validate their use in correlative PATIENTS A N D M ETH OD S Data were collected from 99 out-patients who regularly visited one of four hospitals in the Utrecht area of The Netherlands. Selection criteria were: RA according to the 1987 classification criteria [14] , a minimal age of 20 and a minimal disease duration of 1 yr. Patients participated in a study on behavioural and occupational interventions or were on a waiting list [15] . In the current analysis data comprised two measurements collected after completion of the inter vention. The interval between these measurements was 6 months. During these months on-going an tirheumatic drug therapies were continued. Biomedical measurements at the two time points were carried out by the same rheumatology research nurse; self-report questionnaires were collected on the same day. The characteristics of the patients are shown in Table I .
Two types of biomedical measures were taken: were aiso on ation of four clinical assessments and laboratory measures. Clinical assessments consisted of grip strength (patients were asked to squeeze the cuff of a partially inflated sphyg momanometer as tightly as possible; the mean value of the best grip strength of three attempts in the left and right hand was taken), Thompson joint score (clinical assessment of tender and swollen joints) [16] and 30-m walking time. Blood samples were analysed for erythrocyte sedimentation rate (ESR) (Westergren method), C-reactive protein (CRP; nephelometric), haemoglobin and platelet count (both by Coulter counter).
To assess physical and psychosocial health status, the Impact of Rheumatic Diseases on General Health and Lifestyle (IRGL) self-report questionnaire was used [17] . This validated questionnaire is partly derived from the Arthritis Impact Measurement Scales 1 [18] . Of the seven scales used in the current analyses, three assess the physical dimension of health (mobility, self care and pain), three address psychological discomfort (anxiety, depressive mood and cheerful mood) and one scale assesses the impact of RA upon daily activities such as work, household activities and sleeping (impact daily activities).
Statistical analyses
To estimate test-retest stability of measures Cronbach's a was computed using the SPSS procedure reliabilities [19] . This coefficient reflects the proportion of variance of the mean score of two measurements that is explained by stable individual differences. It can take any value between 0 and 1: a value approaching 1 reflects a stable position of patients towards each other with two repeated measurements. The more repeated measurements are taken of a variable, the better the mean score of a patient reflects the usual position of that patient relative to other patients. The Spearman-Brown formula was used to estimate stability coefficients of health status measures as a function of one to six theoretical measurements [8, 20, 21] , in which the estimate of a single measure ment reflects the proportion of variance o f a single measurement (in the 6-month interval) that must be ascribed to individual differences. estimated stability coefficients show how many measurements are needed to arrive at a specific level of stability. As the required level of stability of a measure depends on the specific use of the measure, no s be considered adequate in all circumstances. For studies into groups of patients coefficients of 0.70 are considered sufficient; for clinical outcome studies with relatively few subjects or examining individual responses to treatment 0.90 may be a minimum [7, 13] .
Lack of change in the test-retest interval as well as the range o f inter-individual differences determine stability estimates. To be able to interpret stability the percentage of patients changing more than 36% relative to initial measurements was com puted for each variable. This 36% criterion has been proposed to the cut-off of clinically important change in individual patients [4] .
-----In all analyses missing values were deleted pair-wise. To meet requirements for parametric statistics transformations were applied where appropriate. 
RESULTS

Stability
Descriptive statistics of the first of the two assess ments are shown in Table II . Estimates of stability coefficients as a function of one to six measurements are shown in Table III . Alpha coefficients are shown in column 2 of Table III . Overall, 65% (a = 0.65) to 94% ( a 0.94) of the observed score variances reflect stable inter-individual differences. The proportion of variance in the group explained by individual differences is high (a 0.78 to 0.94) in five biomedical measures (grip strength, walking time, platelet count, haemoglobin and ESR) and five self-report measures (mobility, self care, anxiety, cheerful mood and impact daily activ ities). Moderate stability (a = 0.65 to 0.72) is observed for Thompson joint score, CRP, pain and depressive mood. Estimates of stability coefficients as a function of one to six measurements (columns 1-6 in Table III) show that with a single assessment the stability co efficients of more than half of the measures, including all clinical observations and self-report measures of functional ability, are greater than 0.70; with three measurements all coefficients are in excess of 0.70. The stability o f two measurements over 6 months was computed using Cronbach's a. This coefficient reflects the proportion of variance of the mean score of two measurements that is explained by stable individual differences. Coefficients of one measurement (reflecting the proportion of variance of scores of a single measure ment that must be ascribed to individual differences) and of three to six measurements were estimated with the Spearman-Brown for mula. From the Table it can be seen how many measurements are needed to arrive at a coefficient of, e.g., 0.70 or 0.
(dotted lines; see text for the meaning of these levels). For instance 90% of the mean values of five repeated measurements of ESR reflect stable individual differences; the remaining 10% reflects 'true' changes in time (e.g. due to changes in disease activity) or measurement error.
Changeability
Taking 36% intra-individual change from the first to the second measurement as a cut-off criterion for clinically relevant change, it was proved that 70% of patients changed at the variables impact daily activities the patients changed at Thompson joint score, whereas (11 %), walking time (8%), platelet count (8%), anxiety the percentages for depressive mood and ESR were 56 (8%), mobility (4%), self care (3%) and haemoglobin and 54, respectively. Also, considerable proportions of (1%). These analyses show that a large part of the the sample changed at CRP (43%), grip strength (34%), cheerful mood (29%) and pain (24%). Few 8 -32, pain 6-25, anxiety 10-40, depressive mood 0--24, cheerful mood  0-24, impact daily activities 10-40 . A large impact of the disease is reflected in low scores for the scales mobility, self care and cheerful mood, and in high scores for the other scales.
sample shows a clinically relevant change between the two assessments and at least some variables. Intra individual changes are especially observed in joint scores, depressive mood, ESR, CRP, grip strength, cheerful mood and pain.
DISCUSSION
Although some variables perform better than others, most of the commonly used health status variables in RA largely reflect stable individual Table III may be used to guide the choice of variables in correlative studies and to decide whether a si measurement or the mean of repeated measurements is to be used.
In the current study the stability of measures of physical functioning (mobility, self care, walking time) reflects a lack of intra-individual change during the course of the study as well as inter-individual differ ences. This contrasts with measures that have been proven to be sensitive to change in clinical trials, e.g. ESR and joint scores [3, 5, 22] . In our study less than 8% of the patients changed more than 36% at physical functioning, while more than half of the patients changed more than 36% at ESR and joint scores. These meaningful changes in a large proportion of the sample did not, however, affect stability to a large extent. This can o n ly mean that the stability of these variables must be explained in terms of individual differences. Due to this b ro ad range of individual scores the relative posi tion o f patients towards each other is maintained, even if a large part of the sample of patients shows clinical am elioration or deterioration while another part does change. The observation of large heterogeneity in h ealth status is in agreement with other studies stability Table III assessment in the first column of be used to decide whether a single to predict future health status or to correlate more enduring characteristics of patients. The estimates of five health measures do not exceed 0.70. Defining a value of 70 a s a relevant boundary, these five measures do provide a reliable characterization of health status 6-month interval of investigation. Whatever of this lower stability, whether it be real fluctuations in disease activity or inaccurate measurea single measurement of these less stable m easures reflects a more temporary and transient state o f affairs. Therefore, correlations with enduring characteristics of patients or with future health status will very likely be low. Taking into account transient variation, the mean score of repeated measurements o f a less stable measure should be used to predict end apply to early RA. It is conceivable that general health and well-being are more affected by inflammatory flares and remissions in patients with a recent dia gnosis, in whom there are less irreversible consequences of the disease, than in later phases of the disease [28] . The stability of measurements within these groups (and therefore, for example, the prediction of future health status) may vary accordingly.
Our study was designed before the American College of Rheumatology (ACR) and EULAR core sets of disease activity measures for RA clinical trials were established [1, 5, 29] . Nevertheless, most disease activity measures from these core sets were included in the current study, viz., a joint score, assessments of pain and physical function and the acute-phase reactants ESR and CRP. The choice of the A CR core set was guided by several validity considerations, especially sensitivity to change in clinical trials and the ability of measures to predict important long-term outcomes in RA. The extent to which the measures of the ACR core set comply with these two types of validity relates strongly to the stability of measures observed in this study. The moderately stable measures (joint scores, ESR and pain) are most sensitive to change in clinical trials, while the highly stable measures of physical function are the stronger predictors of long-term outcome in RA. The fact that certain variables were chosen in the core sets because of their p o in ts rather than a single assessment. The mean of superior characteristics regarding therapy evaluation to five measurements of joint scores, pain and does not mean that these variables are also superior acute-phase reactants reflects individual differences as in predicting disease course or in correlative studies, adequately as does a single assessment of-functional Values of grip strength, walking time, button test and questionnaire scores of activities of daily living proved to have a substantial clinical utility regarding long-term prediction of health status, predicting morbidity and mortality 9 yr later [30]. By inference, it is worthwhile to study the long-term prediction of the other variables repeatedly measured at the same moment. This may that proved to be stable in this study. Stability is an
To be able to remove from the score both the variations that are due to inaccurate measurements and fluctuations of the disease, these measurements should it several time points during the 6-month interval. In the current study only grip strength was have inflated the stability coefficient a little, because true changes during the 6-month interval did important feature of health status variables that should be considered next to (not opposed to) other generally reduce the stability, whereas the reduction of stability recognized features such as sensitivity to change. Stability should guide the choice of variables in cor relative studies and sensitivity to change in evaluation studies. The results of the current study therefore do in o th e r measurements was due to inaccurate measureseems rather representative for a * m A the population of non-hospitalized patients with RA. not give rise to change the ACR preliminary core set in com parison with other samples from the same area, of disease activity measures. Rather, it enhances our the patients did not differ with respect to gender, age insight into the stability of distinct measures of the or duration of the disease [17, 23, 24] . Moreover, the set, and consequently into the applicability of these m ean s and ranges of the measures evaluated do not measures in correlative investigations. 
